Medical News

RSS

Olympus PlasmaButton- vaporization technology now usable with Gyrus ACMI SuperPulse- Generator platform

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products among other core businesses, announced today that its revolutionary PlasmaButton- vaporization technology can now be used with the Gyrus ACMI SuperPulse- Generator platform. Together, the PlasmaButton electrode and SuperPulse Generator provide physicians and patients with a new, virtually bloodless treatment option for benign prostate hyperplasia (BPH) or enlarged prostate.

From Evident Corporation - Life Sciences 3 Dec 2010

FDA accepts to file PMA application for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it was notified by the U.S. Food and Drug Administration (FDA) that the company's premarket approval application (PMA) for the LightTouch Cervical Scanner, for patients at risk for cervical cancer, is suitable for filing.

3 Dec 2010

Jimmy Carter: Kennedy obstructed health care reform in 1970s

In an interview with CBS News, former President Jimmy Carter said "he doesn't have 'any doubt' that [Former Sen. Ted Kennedy, D-Mass.] stood in the way of his administration's plans for national health care insurance.

3 Dec 2010

BMEYE signs licensing agreement with PULSION Medical Systems

BMEYE's Breakthrough Totally Noninvasive Blood Pressure and Cardiac Output Technology Will be Incorporated Into PULSION's Next Generation Patient Monitors

3 Dec 2010

Smoking reduces brain thickness

Many brain imaging studies have reported that tobacco smoking is associated with large-scale and wide-spread structural brain abnormalities.

3 Dec 2010

Minnpost examines foreign aid prospects in new Congress

The MinnPost examines the new Congress' possible approach to foreign aid and international spending.

3 Dec 2010

New study offers hope for children with MPS I genetic disorder

A new study offers hope for children born with a rare genetic disease, according to a paper published by the American Association for the Advancement of Science.

3 Dec 2010

Study raises questions about therapeutic use of botulinum toxin A

A new study by researchers at the Faculty of Kinesiology, University of Calgary, is raising questions about the therapeutic use of botulinum toxin A.

3 Dec 2010

Africa can produce enough food to feed itself, study says

Africa is capable of producing enough food to feed itself within a single generation, according to "a study released to coincide with a meeting of several African leaders in Tanzania on Thursday, as well as U.N. talks on slowing climate change in Cancun, Mexico," Reuters reports (Doyle, 12/2).

3 Dec 2010

FDA accepts IND application to initiate human clinical trial to evaluate BNC

QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that the United States Food and Drug Administration (FDA) has accepted the Investigational New Drug application (IND) to begin human clinical trials and evaluate the safety and efficacy of the company's second product, bisnorcymserine (BNC).

3 Dec 2010

Sirnaomics cemented partnership with Chinese pharmaceutical to develop siRNA therapeutics

Sirnaomics, Inc. announced today that the company has cemented a partnership with a Chinese pharmaceutical company for development of its small interfering RNA (siRNA) therapeutic (STP705) for scarless wound healing.

3 Dec 2010

SAGE launches two new journals in Drug Safety, Hematology

SAGE Expands Therapeutic Advances series by launching two new journals in Drug Safety and Hematology. SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles: Therapeutic Advances in Drug Safety, and Therapeutic Advances in Hematology.

3 Dec 2010

TUM physicist's new approach expected to improve image contrast with low radiation

The DFG cited Pfeiffer's research in biomedical imaging, and in particular his pioneering work in X-ray phase-contrast imaging. His systematic approach has laid the foundation for applications of this technique in medicine and industry, where it is expected to deliver improved image contrast with lower doses of radiation.

3 Dec 2010

Geron commences enrollment in imetelstat Phase 2 clinical trial for metastatic breast cancer

Geron Corporation today announced enrollment of the first patient in a randomized Phase 2 clinical trial of its telomerase inhibitor drug, imetelstat (GRN163L), in combination with paclitaxel (with or without bevacizumab) in patients with locally recurrent or metastatic breast cancer.

3 Dec 2010

Republican governors want health law flexibility, could help insurers with reform

More than a dozen Republican governors-elect plotted ways to unravel the Democrats' health-care overhaul and to give states more freedom in regulating programs like Medicaid during a meeting late Wednesday with incoming Speaker John Boehner and Senate Minority Leader Mitch McConnell.

2 Dec 2010

Arteriocyte launches Stem Cell Expansion System for research use

Arteriocyte, Inc., a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops proprietary stem cell and tissue engineering based therapies announced today the launch of its first commercially available Stem Cell Expansion System for research use.

2 Dec 2010

At Senate hearing, Democrats blast 'mini-med' insurance policies

The New York Times: "More than a million Americans enrolled in [limited benefit, or mini med,] plans think they have health insurance to protect them from financial catastrophe if they become seriously ill or hurt, [Senator John D.] Rockefeller said. 'In fact, they don't,' he said. 'It's worse than nothing because of the false expectations and the false hope,' Mr. Rockefeller said" at the Senate hearing.

2 Dec 2010

New approach to biomarker detection for early lung cancer diagnosis

Even with astounding advances in genomic science, genetic analysis of disease remains largely a measure of risk rather than actual disease state. A truer and more immediate measure of health can be obtained by analysis of proteins, especially those that are biomarkers of disease state.

2 Dec 2010

Xencor, MorphoSys initiate XmAb5574 Phase 1 study in CLL

Xencor, Inc. and MorphoSys AG announced today that they have initiated Phase 1 testing for XmAb®5574 (MOR208), and the first patient has been dosed. XmAb5574 (MOR208) is a potent monoclonal anti-CD19 antibody to which MorphoSys recently gained worldwide access via an exclusive license and collaboration agreement with Xencor.

2 Dec 2010

Trillium presents results from cancer stem cell program at ASH Annual Meeting

Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, today announced that preliminary results from its cancer stem cell program, targeting the CD47 protein, will be reported in an oral presentation at the 52nd American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida, December 4-7, 2010.

2 Dec 2010